{"id":63676,"date":"2022-06-14T12:27:03","date_gmt":"2022-06-14T10:27:03","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=63676"},"modified":"2023-10-09T15:16:46","modified_gmt":"2023-10-09T15:16:46","slug":"novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","title":{"rendered":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria"},"content":{"rendered":"\n

El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> va acollir la formaci\u00f3 “C\u00e0ncer renal. Actualitzaci\u00f3 terap\u00e8utica”<\/strong>, organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a> i que va comptar amb la col\u00b7laboraci\u00f3 d’IPSEN<\/a>. Els ponents van ser Alejo Rodr\u00edguez<\/strong>, onc\u00f2leg adjunt del Servei d’Oncologia M\u00e8dica de la Unitat Funcional de C\u00e0ncer Urol\u00f2gic de l’Hospital del Marc, David L\u00f3pez<\/strong>, farmac\u00e8utic adjunt al Servei de Farm\u00e0cia a l’Institut Catal\u00e0 d’Oncologia (ICO), i Montse Gasol<\/strong> farmac\u00e8utica de la Divisi\u00f3 de l’\u00das Racional del Medicament i secret\u00e0ria del Consell Assessor de la Medicaci\u00f3 Hospital\u00e0ria, Ger\u00e8ncia del Medicament de l’\u00c0rea Assistencial del Servei Catal\u00e0 de Salut. David Conde<\/strong>, vocal d’Hospitals del COFB, va moderar la sessi\u00f3.<\/p>\n\n\n\n

\"\"
D’esquerra a dreta, Alejo Rodr\u00edguez, Montse Gasol, David Conde, i David L\u00f3pez durant la taula de debat.<\/figcaption><\/figure>\n\n\n\n

Adre\u00e7ada a farmac\u00e8utics hospitalaris, els objectius d’aquesta sessi\u00f3 es van centrar a con\u00e8ixer les novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal, explicar les decisions de posicionament i selecci\u00f3 de ter\u00e0pies, i debatre al voltant dels tractaments d’aquesta patologia. <\/p>\n\n\n\n

El c\u00e0ncer renal i els seus factors de risc<\/strong><\/h2>\n\n\n\n

Alejo Rodr\u00edguez<\/strong>, va iniciar la sessi\u00f3 definint el c\u00e0ncer renal i parlant sobre els tractaments disponibles per fer-li front. Va remarcar: “\u00e9s el c\u00e0ncer m\u00e9s prevalent tant en homes com en dones.<\/strong> Acostuma a apar\u00e8ixer<\/strong> entre els 40 i 60 anys<\/strong> i la seva incid\u00e8ncia m\u00e9s alta<\/strong> \u00e9s entre els 60 i 80 anys<\/strong>“. <\/p>\n\n\n

\n\n\n

La import\u00e0ncia de la detecci\u00f3 preco\u00e7 en el c\u00e0ncer renal<\/strong><\/h3>\n\n\n\n

El carcinoma de c\u00e8l\u00b7lules renals (CCR)<\/strong> \u00e9s el m\u00e9s freq\u00fcent dels c\u00e0ncers renals en adults, representant aproximadament el 90%<\/strong> de les neopl\u00e0sies de rony\u00f3. El c\u00e0ncer de rony\u00f3 \u00e9s asimptom\u00e0tic<\/strong> en les primeres etapes<\/strong>, \u00e9s per aix\u00f2 que aproximadament un 25%-30%<\/strong> dels pacients presenten malaltia metast\u00e0tica<\/strong> en el moment del diagn\u00f2stic.<\/p>\n\n\n\n

La superviv\u00e8ncia dels pacients amb c\u00e0ncer renal ha millorat en els \u00faltims anys<\/strong> gr\u00e0cies a la disponibilitat de tractaments<\/strong> dirigits a incrementar la detecci\u00f3 preco\u00e7<\/strong> de tumors de petit volum<\/strong>. L\u2019esperan\u00e7a de vida dels pacients amb CCR dep\u00e8n de l\u2019estadi del tumor en el moment del diagn\u00f2stic, de manera que els pacients amb tumor localitzat <\/strong>tenen una probabilitat de curaci\u00f3 molt alta<\/strong> i una superviv\u00e8ncia, al cap de 5 anys, d\u2019entre el 70% i 90%, mentre que nom\u00e9s el 10% dels pacients amb met\u00e0stasis en el moment del diagn\u00f2stic mostren una superviv\u00e8ncia despr\u00e9s de 5 anys. <\/p> <\/div>\n\n\n\n

Pel que fa als factors de risc<\/strong> causants d’aquesta malaltia, l’onc\u00f2leg va explicar que “no \u00e9s una patologia que tingui un factor de risc determinant, \u00e9s un tumor multifactorial<\/strong>. Hi ha molts aspectes que sumen, per\u00f2 no hi ha cap que sigui clarament el causant de la malaltia”. Tot i aix\u00f2, alguns detonants poden ser “el tabac<\/strong>, l’exposici\u00f3 laboral<\/strong> al cadmi<\/strong>, amiant <\/strong>i petroli<\/strong>, s\u00edndromes metab\u00f2lics com l’obesitat<\/strong>, la hipertensi\u00f3 <\/strong>o la diabetis<\/strong>, i l’historial familiar<\/strong>“. <\/p>\n\n\n\n

\"L'onc\u00f2leg
L’onc\u00f2leg Alejo Rodr\u00edguez a l’inici de la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

El cicle del medicament i el proc\u00e9s de comercialitzaci\u00f3<\/strong><\/h2>\n\n\n\n

Seguidament, David L\u00f3pez<\/strong>, va parlar sobre el cicle del medicament<\/strong> i el proc\u00e9s de<\/strong> comercialitzaci\u00f3<\/strong> en la gesti\u00f3 dels tractaments innovadors del c\u00e0ncer renal en la farm\u00e0cia hospital\u00e0ria.<\/p>\n\n\n\n

El farmac\u00e8utic va explicar que “darrere de la farm\u00e0cia hi ha tota una s\u00e8rie de passos que impliquen el desenvolupament b\u00e0sic del cicle del medicament<\/strong>: la investigaci\u00f3 b\u00e0sica o registre del medicament, la investigaci\u00f3 precl\u00ednica, la investigaci\u00f3 cl\u00ednica, el registre i, per \u00faltim, el llan\u00e7ament del f\u00e0rmac”. <\/p>\n\n\n\n

Pel que fa al proc\u00e9s de comercialitzaci\u00f3<\/strong>, L\u00f3pez<\/strong> va recordar els tr\u00e0mits que ha de fer el f\u00e0rmac fins a arribar a l’oficina de farm\u00e0cia: “inicialment, el f\u00e0rmac ha de tenir una autoritzaci\u00f3. Despr\u00e9s, es notifica al laboratori. A partir d’aqu\u00ed, cal fer la sol\u00b7licitud de preu i finan\u00e7ament, l’avaluaci\u00f3 d’informes t\u00e8cnics, la negociaci\u00f3 del preu, la fixaci\u00f3 del preu i condicions de finan\u00e7ament, la comercialitzaci\u00f3, i, per \u00faltim, l’avaluaci\u00f3 del f\u00e0rmac per part de diferents comissions de les comunitats aut\u00f2nomes”. <\/p>\n\n\n\n

\"\"
El farmac\u00e8utic David L\u00f3pez en un moment de la seva intervenci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Per concloure la sessi\u00f3, els ponents van conformar una taula de debat<\/strong> al voltant d’aquesta patologia, on es va afegir Montse Gasol,<\/strong> farmac\u00e8utica i secret\u00e0ria del Consell Assessor de la Medicaci\u00f3 Hospital\u00e0ria. Gasol, en relaci\u00f3 amb el mercat farmac\u00e8utic<\/strong>, va voler destacar que “ha canviat molt<\/strong>. Els costos han incrementat, i aix\u00f2 s’ha de tenir en compte a escala estatal. L’administraci\u00f3 de la comunitat aut\u00f2noma \u00e9s qui t\u00e9 el pressupost, ja que a Espanya hi ha un sistema descentralitzat, per tant, s’ha de tenir una \u00e0mplia visi\u00f3 del sistema sanitari <\/strong>i les patologies a tractar per preservar el benestar de la ciutadania<\/strong>“. <\/p>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Activitat organitzada conjuntament amb:<\/strong><\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n

Amb la col\u00b7laboraci\u00f3:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure> <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir la formaci\u00f3 “C\u00e0ncer renal. Actualitzaci\u00f3 terap\u00e8utica”, organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica i que va comptar amb la col\u00b7laboraci\u00f3 d’IPSEN. Els ponents van ser Alejo Rodr\u00edguez, onc\u00f2leg adjunt del Servei d’Oncologia M\u00e8dica de la […]<\/p>\n","protected":false},"author":1,"featured_media":67896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[748,749,18,19,255,50,52,68,480,70,45,750,76,724,631,751,752,63],"class_list":["post-63676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cancer-renal","tag-carcinoma","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-deteccio-precoc","tag-diagnostic","tag-farmaceutic","tag-farmacia","tag-farmacia-hospitalaria","tag-formacio","tag-medicaments","tag-mercat-farmaceutic","tag-oficina-de-farmacia","tag-oncologia","tag-patologia","tag-supervivencia","tag-terapia","tag-tractament"],"yoast_head":"\nNovetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T10:27:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-09T15:16:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"738\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\",\"datePublished\":\"2022-06-14T10:27:03+00:00\",\"dateModified\":\"2023-10-09T15:16:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"},\"wordCount\":902,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"keywords\":[\"C\u00e0ncer renal\",\"carcinoma\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"detecci\u00f3 preco\u00e7\",\"diagn\u00f2stic\",\"farmac\u00e8utic\",\"Farm\u00e0cia\",\"farm\u00e0cia hospital\u00e0ria\",\"Formaci\u00f3\",\"medicaments\",\"mercat farmac\u00e8utic\",\"Oficina de farm\u00e0cia\",\"oncologia\",\"patologia\",\"superviv\u00e8ncia\",\"ter\u00e0pia\",\"tractament\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\",\"name\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"datePublished\":\"2022-06-14T10:27:03+00:00\",\"dateModified\":\"2023-10-09T15:16:46+00:00\",\"description\":\"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg\",\"width\":738,\"height\":416},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","og_locale":"ca_ES","og_type":"article","og_title":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","og_url":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-06-14T10:27:03+00:00","article_modified_time":"2023-10-09T15:16:46+00:00","og_image":[{"width":738,"height":416,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria","datePublished":"2022-06-14T10:27:03+00:00","dateModified":"2023-10-09T15:16:46+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"},"wordCount":902,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","keywords":["C\u00e0ncer renal","carcinoma","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","detecci\u00f3 preco\u00e7","diagn\u00f2stic","farmac\u00e8utic","Farm\u00e0cia","farm\u00e0cia hospital\u00e0ria","Formaci\u00f3","medicaments","mercat farmac\u00e8utic","Oficina de farm\u00e0cia","oncologia","patologia","superviv\u00e8ncia","ter\u00e0pia","tractament"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","url":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/","name":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l'\u00e0mbit de la farm\u00e0cia hospital\u00e0ria - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","datePublished":"2022-06-14T10:27:03+00:00","dateModified":"2023-10-09T15:16:46+00:00","description":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir una nova formaci\u00f3 sobre c\u00e0ncer renal.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg","width":738,"height":416},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/06\/14\/novetats-en-el-diagnostic-i-el-tractament-del-cancer-renal-en-lambit-de-la-farmacia-hospitalaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Novetats en el diagn\u00f2stic i el tractament del c\u00e0ncer renal en l’\u00e0mbit de la farm\u00e0cia hospital\u00e0ria"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",738,416,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB-Cancer-Renal-26052022-2.jpg",18,10,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 26 de maig el Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir la formaci\u00f3 “C\u00e0ncer renal. Actualitzaci\u00f3 terap\u00e8utica”, organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica i que va comptar amb la col\u00b7laboraci\u00f3 d’IPSEN. Els ponents van ser Alejo Rodr\u00edguez, onc\u00f2leg adjunt del Servei d’Oncologia M\u00e8dica de la […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=63676"}],"version-history":[{"count":4,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63676\/revisions"}],"predecessor-version":[{"id":69028,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63676\/revisions\/69028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67896"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=63676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=63676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=63676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}